The discovery of factor X

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 187-188

  Girolami, Antonio ^a   Denson, Ken W E ^b   Hougie, C ^c,d  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Thame Thromb/Haemostasis Res Found   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 6; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; PROTHROMBIN COMPLEX;

ARTICLE; BLEEDING TENDENCY; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BLOOD CLOTTING TIME; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; FREEZE DRYING; HISTORY OF MEDICINE; HUMAN; MEDICAL LITERATURE; NOMENCLATURE; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOPLASTIN TIME;

EID: 13244259436     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.0627a.x     Document Type: Article

References (43)

1. Graham JB. Stuart Factor. Discovery and designation as factor X. J Thromb Haemost 2003; 1: 871-2.
2. Telfer TP, Denson KW, Wright DR. A 'new' coagulation defect. Br J Haematol 1956; 1: 308-12.
3. Bachmann F, Duckert F, Fluckiger P, Hitzig WH. Hämorrhagische Diathesen, verursacht durch Mangel des Stuart-Prower-Faktors. Schweiz Med Wochenschrift 1957; 87: 1221-5.
4. Hougie C, Barrow HM, Graham JB. Stuart clotting defect I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called 'stable factor' (SPCA, proconvertin, factor VII) deficiency. J Clin L Invest 1957; 36: 485-96.
5. Graham JB, Barrow EM, Hougie C. Stuart clotting defect. II. Genetic aspects of a 'new' hemorrhagic state. J Clin L Invest 1957; 36: 497-503.
6. Girolami A, Molaro G, Lazzarin M, Scarpa R. Una nuova coagulopatia emorragica congenital probabilmente dovuta alla presenza di un fattore X anormale. Min Med 1969; 60: 4939-49.
7. Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. Congenital hemorrhagic condition similar but not identical to factor X deficiency. A hemorrhagic state due to abnormal factor X ? Scand J Haematol 1970; 7: 91-5.
8. Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A 'new' congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred. Br J Haematol 1970; 19: 179-92.
9. Bachmann F, Duckert F, Koller F. The Stuart-Prower factor assay and its clinical significance. Tromb Diath Haemorrh 1958; 2: 24-8.
10. Owen W, Bowie EJW, Thompson JM. The Diagnosis Of Bleeding Disorders. Boston: Little, Brown and Co, 1975: 25.
11. Biggs R, ed. Human Blood Coagulation, Haemostasis and Thrombosis. Oxford: Blackwell Science, 1972: 5.
12. Chevallier P, Bernard J, Bilski-Pasquier G, De Grouchy J, Samama M. Déficience congénital et familiale en facteur Stuart. Sang 1959; 30: 525-30.
13. Chevallier P, Bernard J, Fieherer A, Bilski-Pasquier G, Samama M, Cerf M. Deux cas d'hypoproconvertinemie familiale. Sang 1955; 25: 650-5.
14. Venturelli R, Molaro GL, Camoretto R. Intervento chirurgico in soggetto affetto da deficit congenito del complesso protrombinico. Trasf Sangue 1961; 6: 34-5.
15. Denson KW, Lurie A, De Cataldo F, Mannucci PM. The factor-X defect: recognition of abnormal forms of factor X. Br J Haematol 1970; 18: 317-27.
16. Cooper DN, Millar DS, Wacey A, Pemberton S, Tuddenham EG. Inherited factor X deficiency: molecular genetics and pathophysiology. Thromb Haemost 1997; 78: 161-72.
17. Graham JB. Stuart Factor: discovery and designation as factor X. J Thromb Haemost 2003; 1: 871-7.
18. Telfer TP, Denson KW, Wright DRA 'New' coagulation defect. Br J Haematol 1956; 2: 308-16.
19. Alexander B, Goldstein R, Landwehr G, Cook CD. Congenital SPCA deficiency; a hitherto unrecognised coagulation defect with haemorrhage rectified by serum and serum fractions. J Clin Invest 1951; 30: 596.
20. Biggs R, Douglas AS. The thromboplastin generation test. J Clin Pathol 1953; 6: 23.
21. Lewis JH, Ferguson JH. Congenital hypoproconvertinaemia. Proc Soc Exp Biol Med 1953; 84: 651-4.
22. Hougie C, Barrow EM, Graham JB. Stuart Clotting Defect 1. Segregation of an hereditary haemorrhagic state from the heterogeneous group heretofore called 'Stable Factor' (SPCA, proconvertin, Factor VII). J Clin Invest 1957; 36: 485-96.
23. Graham JB, Barrow EM, Hougie C. Stuart Clotting defect II. Genetic aspects of a 'new' haemorrhagic state. J Clin Invest 1957; 36: 497-503.
24. Denson KW. The specific assay of Prower-Stuart Factor and Factor VII. Acta Haematol 1961; 25: 105-20.
25. Bachmann F, Duckert F, Fluckiger P, Hitzig WH. Hamorrhagische Diathesen, verursacht durch Mangel des Stuart-Prower-Factors. Schweiz Med Wochenschrift 1957; 87: 1221-5.
26. Denson KWE, Biggs R, Mannucci PM. An investigation of three patients with Christmas disease due to an abnormal type of factor IX. J Clin Pathol 1968; 21: 160-5.
27. Denson KWE, Lurie A, De Cataldo F, Mannucci PM. The factor-X defect. Recognition of abnormal forms of factor X. Br J Haematol 1970; 18: 317-27.
28. Girolami A, Molaro G, Lazzarin M, Scarpa R, Brunetti A. A 'new'-congenital haemorrhagic condition due to the presence of an abnormal factor X (factor X Friuli): study of a large kindred. Br J Haematol 1970; 19: 179-92.
29. Vianello F, Lombardi AM, Bello FD, Palu G, Zanon E, Girolami A. A novel type 1 factor X variant (factor X cys350Phe) due to loss of a disulphide bond in the catalytic domain. Blood Coagul Fibrinolysis 2003; 14: 401-5.
30. Graham JB. Stuart factor (coagulation factor X). A North Carolina saga. NC Med J 1988; 49: 328-41.
31. Graham JB. Stuart factor: discovery and designation as factor X. J Thromb Haemost 2003; 1: 871-7.
32. Telfer TP, Denson KW, Wright DR. A 'new' coagulation defect. Br J Haematol 1956; 2: 308-16.
33. Hougie C, Barrow EM, Graham JB. Stuart clotting defect I. Segregation of a hereditary hemorrhagic state from the heterogeneous group heretofore called 'Stable Factor' (SPCA, proconvertin, Factor VII). J Clin Invest 1957; 36: 485-96.
34. Denson KWE, Lurie A, Cataldo de F, Mannucci PM. The factor X defect. Recognition of abnormal forms of factor X. Br J Haematol 1970; 18: 317-27.
35. Lewis JH, Fresh JW, Ferguson JH. Congenital hypoproconvertinemia. Proc Soc Exp Biol Med 1953; 84: 651-4.
36. Duckert F, Fluckiger P, Matter M, Koller F. Clotting factor X. Physiological and physiochemical properties. Proc Soc Exp Biol Med 1955; 90: 17-22.
37. Graham JB, Barrow EM. Pathogenesis of hemophilia: an experimental analysis of the anticephalin hypothesis in hemophilic dogs. J Exp Med 1957; 27: 273-92.
38. Graham JB, Barrow EM, Hougie C. Stuart clotting defect II. Genetic aspects of a 'new' hemorrhagic state. J Clin Invest 1957; 36: 497-503.
39. Hougie C. Reactions of Stuart factor and factor VII with brain and factor V. Proc Soc Exp Biol Med 1959; 101: 132-5.
40. Hougie C. The role of factor V in the formation of blood thromboplastin. J Lab Clin Med 1957; 50: 61-8.
41. Hougie C. Effect of Russell's viper venom (Stypven) on Stuart clotting defect. Proc Soc Exp Biol Med 1956; 93: 570-3.
42. Bachmann F, Duckert F, Koller F. The Stuart-Prower factor assay and its clinical significance. Thromb Diath Haemorrh 1958; 2: 24-38.
43. Graham JB, Barrow EM, Wynne TR. Stuart Clotting Defect III. An acquired case with complete recovery. In: Brinkhous KM, ed. Hemophilia and Other Hemorrhagic States. UNC Press, 1959: 158-66.